News related to Tasigna (Nilotinib) and/or conditions it is approved for
Data show new Roche leukemia drug may improve on Rituxan
Source: Yahoo! Health News [2013.05.16]
By Bill Berkrot (Reuters) - An experimental leukemia treatment that Roche Holding AG hopes will improve upon its best-selling cancer drug Rituxan delayed disease progression twice as long as chemotherapy, according to preliminary trial data releas...
Possible New Acute Leukemia Marker Treatment Target Identified
Source: Genetics News From Medical News Today [2013.05.15]
A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope (that is, cytogenetically normal acute myeloid leukemia, or CN-AML). The study was led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G...
Drug Combo Looks Promising For Chronic Lymphocytic Leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2013.05.15]
Doctors at Dartmouth-Hitchcock's Norris Cotton Cancer Center (NCCC) have found a combination of drugs to potentially treat chronic lymphocytic leukemia (CLL) more effectively. The research was published online recently, and it will appear as a letter in the journal Leukemia, a publication of the prestigious Nature Publishing Group. The study helps address a basic problem of treating CLL...
Leukemia Drug Prevents Build-Up Of Toxic Brain Protein
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2013.05.14]
Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson's disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects...
Genetic Test Identifies Two Types Of Leukemia; Discovery Provides Insights Into New Treatment Approach
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2013.05.14]
Research method used by scientists with the Knight Cancer Institute at Oregon Health & Science University shows promise in accelerating advances in personalized cancer medicine Patients with two forms of leukemia, who currently have no viable treatment options, may benefit from existing drugs developed for different types of cancer, according to a study conducted by research...
Gene Discovery May Offer Breakthrough for Rare Leukemia
Source: MedicineNet Clinical Trials Specialty [2013.05.10]
Title: Gene Discovery May Offer Breakthrough for Rare Leukemia
Category: Health News
Created: 5/9/2013 12:35:00 PM
Last Editorial Review: 5/10/2013 12:00:00 AM
Researchers Identify Mutations That Cause Blood Cancer Acute Myeloid Leukemia (AML)
Source: Blood / Hematology News From Medical News Today [2013.05.03]
A group of researchers has just identified all of the genetic mutations that cause blood cancer acute myeloid leukemia (AML), which could help drive further research for newer and better treatments for AML. The research, which was published online in The New England Journal of Medicine, could help base treatments for AML according to the genetic profile of the patient's cancer...
Computer Scientists Assemble The Most Complete Genetic Profile Yet Of Acute Myeloid Leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2013.05.03]
Powerful data-sifting algorithms developed by computer scientists at Brown University are helping to untangle the profoundly complex genetics of cancer. In a study reported today in the New England Journal of Medicine, researchers from Washington University in St...
Patients' Health May Be Jeopardized By High Leukemia Treatment Costs
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2013.04.29]
The increasing cost of treatments for chronic myeloid leukemia (CML) in the United States has reached unsustainably high levels and may be leaving many patients under - or untreated because they cannot afford care, according to a Blood Forum article supported by nearly 120 CML experts from more than 15 countries on five continents and published online in Blood, the Journal of t...
Effective Leukemia Drugs Too Expensive, Desperate Patients Left Untreated
Source: Blood / Hematology News From Medical News Today [2013.04.26]
Eleven of the 12 drugs approved for treating chronic myeloid leukemia (CML) and some other cancers cost over $100,000 per year, leaving many desperate patients either untreated or under-treated because they simply cannot afford care, nearly 120 CML experts from over 15 countries reported today in the journal Blood...
Soaring Prices Keep Leukemia Drugs From Patients, Experts Say
Source: MedicineNet Leukemia Specialty [2013.04.26]
Title: Soaring Prices Keep Leukemia Drugs From Patients, Experts Say
Category: Health News
Created: 4/25/2013 2:36:00 PM
Last Editorial Review: 4/26/2013 12:00:00 AM
Prevention Hope For Acute Myeloid Leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2013.04.19]
Researchers from the RIKEN Center for Integrative Medical Sciences in Japan have reported that they have identified a compound that could be used as a new treatment to prevent relapse in acute myeloid leukemia patients. In a study published in Science Translational Medicine, they show that this compound reduces the risk of relapse in a mouse model of the human disease...
Disabling Major Pro-Survival Proteins In Leukemia, Combination Therapy Also Helps To Unleash Several Additional Proteins That Promote Apoptosis
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2013.04.19]
A new, pre-clinical study by researchers at Virginia Commonwealth University Massey Cancer Center suggests that a novel drug combination could lead to profound leukemia cell death by disrupting the function of two major pro-survival proteins...
Protein Helps Leukemia Cells Avoid Effects Of Chemotherapy By Appearing Dormant
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2013.04.17]
A new study on how the progression of acute lymphocytic leukemia (ALL) is influenced by the bone marrow environment has demonstrated for the first time that targeting a specialized protein known as osteopontin (OPN) may be an effective strategy to increase the efficacy of chemotherapy in patients with this type of blood cancer...
Immune Therapy Shows Early Promise for Advanced Leukemia
Source: MedicineNet Leukemia Specialty [2013.03.21]
Title: Immune Therapy Shows Early Promise for Advanced Leukemia
Category: Health News
Created: 3/20/2013 4:35:00 PM
Last Editorial Review: 3/21/2013 12:00:00 AM
Gene Mutations Appear Key to Childhood Leukemia Risk, Study Says
Source: MedicineNet Leukemia Specialty [2013.03.20]
Title: Gene Mutations Appear Key to Childhood Leukemia Risk, Study Says
Category: Health News
Created: 3/19/2013 4:35:00 PM
Last Editorial Review: 3/20/2013 12:00:00 AM
Leukemia Patients Get Treatment Boost From Donors' Immune Cells
Source: MedicineNet Leukemia Specialty [2013.02.28]
Title: Leukemia Patients Get Treatment Boost From Donors' Immune Cells
Category: Health News
Created: 2/27/2013 2:36:00 PM
Last Editorial Review: 2/28/2013 12:00:00 AM
Cancer Chemotherapy Tied to Slight Rise in Risk for Leukemia
Source: MedicineNet Cervical Cancer Specialty [2013.02.15]
Title: Cancer Chemotherapy Tied to Slight Rise in Risk for Leukemia
Category: Health News
Created: 2/14/2013 12:36:00 PM
Last Editorial Review: 2/15/2013 12:00:00 AM
Iclusig Approved for Rare Leukemias
Source: MedicineNet Leukemia Specialty [2012.12.17]
Title: Iclusig Approved for Rare Leukemias
Category: Health News
Created: 12/14/2012 4:36:00 PM
Last Editorial Review: 12/17/2012 12:00:00 AM
Leukemia Drug Is Highly Effective MS Treatment
Source: MedicineNet interferon Specialty [2012.11.01]
Title: Leukemia Drug Is Highly Effective MS Treatment
Category: eMedicine Health News
Created: 11/1/2012 12:16:00 PM
Last Editorial Review: 11/1/2012 12:16:24 PM
Childhood Acute Lymphoblastic Leukemia (ALL)
Source: MedicineNet Down Syndrome Specialty [2012.02.03]
Title: Childhood Acute Lymphoblastic Leukemia (ALL)
Category: Diseases and Conditions
Created: 10/28/2009 5:07:00 PM
Last Editorial Review: 2/3/2012 12:00:00 AM
Two-Drug Combo May Help Hard-to-Treat Leukemia
Source: MedicineNet rituximab Specialty [2011.10.12]
Title: Two-Drug Combo May Help Hard-to-Treat Leukemia
Category: Health News
Created: 10/12/2011 11:01:00 AM
Last Editorial Review: 10/12/2011 12:00:00 AM
Chronic Myelogenous Leukemia (CML)
Source: MedicineNet Bone Marrow Specialty [2011.06.14]
Title: Chronic Myelogenous Leukemia (CML)
Category: Doctor's Views
Created: 11/11/2009 2:29:00 PM
Last Editorial Review: 6/14/2011 12:00:00 AM
Childhood Leukemia, Brain Cancer on the Rise
Source: MedicineNet Asbestos-Related Disorders Specialty [2011.01.27]
Title: Childhood Leukemia, Brain Cancer on the Rise
Category: Health News
Created: 1/27/2011 11:00:00 AM
Last Editorial Review: 1/27/2011 12:00:00 AM
Leukemia
Source: MedicineNet Eosinophilic Fasciitis Specialty [2009.06.24]
Title: Leukemia
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 6/24/2009 12:00:00 AM
New benchmark study of unrelated bone marrow transplantation for leukemia
Source: The Doctors Lounge - Hematology
Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors.
Hot On The TRAIL Of Graft Vs. Host Disease
Source: Health News from Medical News Today [2013.05.17]
For patients with leukemia and other hematological malignancies, transplantation of hematopoietic stem cells (HSCT) can be a powerfully effective therapy. In addition to the desirable anti-tumor effect, transplanted cells can also attack the host tissue, resulting in graft-versus-host disease (GVHD). In this issue of the Journal of Clinical Investigation, Arnab Ghosh and colleagues at Memorial Sloan-Kettering Cancer Center found that expression of a protein that causes cell death, TRAIL, in transplanted cells was critical for an effective anti-tumor response...
AstraZeneca accelerates cancer drug testing
Source: Yahoo! Health News [2013.05.16]
By Ben Hirschler LONDON (Reuters) - AstraZeneca has enrolled the first patient into a final-stage clinical trial of a new drug for a rare type of leukemia as the group's new CEO delivers on a promise to accelerate its oncology programs. Britai...
Novartis Loses In Patent Court Ruling, India
Source: Pharma Industry / Biotech Industry News From Medical News Today [2013.04.01]
India's Supreme Court turned down Novartis' patent bid for an updated version of Glivec (imatinib mesylate), its blockbusting leukemia medication, saying that the updated compound "did not satisfy the test of novelty or inventiveness" required by the country's legislation. The ruling means that generic drugmakers can continue manufacturing and selling copies of Glivec at low prices...
Novel Gene Important For Craniofacial Development Implicated In Facial Cleft Birth Defects
Source: Cleft Palate News From Medical News Today [2012.05.04]
In the United States, a baby is born with a facial cleft every hour, of every day of the year! Such birth defects result from both gene mutations and environmental insults. PRDM16 is a transcription factor originally described as being aberrantly activated in specific types of leukemia's, and more recently as a master regulator of brown adipose tissue differentiation...
|
